(Q45098735)

9 December 2017

title

p-Glycoprotein expression as a predictor of breast cancer recurrence (English)

1 reference

9 December 2017

S Gregorcyk

1

1 reference

9 December 2017

Y Kang

2

1 reference

9 December 2017

D Brandt

3

1 reference

9 December 2017

P Kolm

4

1 reference

9 December 2017

G Singer

5

1 reference

9 December 2017

R R Perry

6

1 reference

9 December 2017

publication date

1 January 1996

1 reference

Annals of Surgical Oncology

9 December 2017

published in

1 reference

9 December 2017

volume

3

1 reference

9 December 2017

issue

1

1 reference

9 December 2017

page(s)

8-14

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02409045

9 December 2017

exact match

0 references

cites work

P-glycoprotein expression in treated and untreated human breast cancer

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02409045

Comparison of three commercially available antibodies for flow cytometric monitoring of P-glycoprotein expression in tumor cells

21 January 2018

1 reference

12 December 2020

Radiation sensitivity in vitro of primary tumors and metastatic lesions of malignant melanoma

1 reference

12 December 2020

The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53.

1 reference

12 December 2020

The cell biology of multiple drug resistance

1 reference

12 December 2020

P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil

1 reference

12 December 2020

Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.

1 reference

12 December 2020

The p53 tumor suppressor protein, a modulator of cell proliferation

1 reference

12 December 2020

Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification.

1 reference

12 December 2020

Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer

1 reference

12 December 2020

Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis

1 reference

12 December 2020

Prognostic factors for breast cancer: have they met their promise?

1 reference

12 December 2020

P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors

1 reference

12 December 2020

Tumor progression: potential role of unstable genomic changes

1 reference

12 December 2020

A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors

1 reference

12 December 2020

Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood

1 reference

12 December 2020

P-glycoprotein and tumor progression.

1 reference

12 December 2020

Immunohistochemical detection and quantitation of P-glycoprotein in multiple drug-resistant human myeloma cells: association with level of drug resistance and drug accumulation

1 reference

12 December 2020

Expression of the MDR1 gene (P-glycoprotein) in breast cancer

1 reference

12 December 2020

P-170 glycoprotein, glutathione and associated enzymes in relation to chemoresistance of primary human renal cell carcinomas.

1 reference

12 December 2020

Clinical Relevance of Immunohistochemical Detection of Multidrug Resistance P-Glycoprotein in Breast Carcinoma

1 reference

12 December 2020

MDR1 gene expression and its clinical relevance in primary gastric carcinomas.

1 reference

12 December 2020

P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma

1 reference

12 December 2020

Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis

1 reference

12 December 2020

P-glycoprotein expression in multidrug-resistant human ovarian carcinoma cell lines.

1 reference

12 December 2020

Steroid receptors and other prognostic factors in primary breast cancer

1 reference

12 December 2020

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

1 reference

12 December 2020

Modulatory effects of tamoxifen and recombinant human alpha-interferon on doxorubicin resistance.

1 reference

12 December 2020

Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators.

1 reference

12 December 2020

Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications.

1 reference

12 December 2020

Six-year results of a multimodality treatment strategy for locally advanced breast cancer

1 reference

12 December 2020

The expression of the multidrug resistance-associated glycoprotein in B-cell chronic lymphocytic leukaemia

1 reference

12 December 2020

Adjuvant therapy for node-negative breast cancer. The use of prognostic factors in selecting patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02409045

1 reference

Dimensions Publication ID

9 December 2017

1016270446

0 references

1 reference